Hhlr Advisors LTD. Purchases 3,975 Shares of Danaher Co. (NYSE:DHR)

Hhlr Advisors LTD. increased its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 43.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,079 shares of the conglomerate's stock after acquiring an additional 3,975 shares during the quarter. Danaher makes up about 0.1% of Hhlr Advisors LTD.'s holdings, making the stock its 27th largest position. Hhlr Advisors LTD.'s holdings in Danaher were worth $3,002,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Caden Capital Partners LP grew its position in Danaher by 79.8% during the fourth quarter. Caden Capital Partners LP now owns 209,149 shares of the conglomerate's stock valued at $48,010,000 after buying an additional 92,795 shares during the period. Northern Trust Corp boosted its stake in Danaher by 14.3% in the fourth quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock valued at $1,821,477,000 after acquiring an additional 992,594 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Danaher by 4.6% during the 4th quarter. The Manufacturers Life Insurance Company now owns 1,945,109 shares of the conglomerate's stock valued at $446,500,000 after acquiring an additional 85,010 shares during the period. Bellwether Advisors LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $135,000. Finally, Marshall & Sterling Wealth Advisors Inc. purchased a new position in Danaher in the fourth quarter valued at approximately $257,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several brokerages have issued reports on DHR. Jefferies Financial Group lowered their target price on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Wells Fargo & Company reduced their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Barclays upped their price target on shares of Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research note on Tuesday, April 22nd. Finally, Raymond James reiterated a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $264.40.

Insiders Place Their Bets

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. The trade was a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Danaher Price Performance

Danaher stock traded up $2.44 during mid-day trading on Friday, hitting $199.15. 3,159,138 shares of the company traded hands, compared to its average volume of 3,367,010. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a one year low of $171.00 and a one year high of $281.70. The stock has a market cap of $142.53 billion, a price-to-earnings ratio of 37.72, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The stock has a fifty day moving average price of $199.78 and a 200-day moving average price of $222.10.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. On average, equities analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Investors of record on Friday, March 28th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.64%. This is a boost from Danaher's previous quarterly dividend of $0.27. The ex-dividend date was Friday, March 28th. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.